NCT05097976View on ClinicalTrials.gov

Medrol Dosepak for Outpatient Total Knee Arthroplasty

PHASE4RecruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions
Total Knee Arthroplasty
Interventions
DRUG

Methylprednisolone

21 x 4mg tablets beginning on POD 1

DRUG

Placebo

21 sugar tablets beginning on POD 1 with standard management

Trial Locations (1)

60523

RECRUITING

Rush Oak Brook Outpatient Center, Oak Brook

All Listed Sponsors
lead

Rush University Medical Center

OTHER

NCT05097976 - Medrol Dosepak for Outpatient Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter